Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Bullboard Posts
Comment by jsnfernleyon May 16, 2010 11:22am
303 Views
Post# 17103487

RE: Strange statements regarding drill program?

RE: Strange statements regarding drill program?From the most recent MD&A on sedar.com:

"The drill rig was mobilised to the Malartic H property to complete the $1.2M work commitment under the
terms of the Breakwater-Atlanta Gold option agreement. A total of 46 holes for 7,400 metres are
proposed. Four holes are planned to confirm the best intersections on the H Zone of which one hole was
completed and one hole was in progress at the end of the Current Period. The remaining holes are planned
to locate and investigate the western extension the North and North-North structures."

This is from the Malartic property project on the company web site:

"Upside

NioGold has consolidated a large land package within the heart of anestablished gold mining district in the mining friendly jurisdiction ofQuebec that permits for cost effective exploration and development. Thegrounds were acquired for their potential for near term gold resourcedefinition and cover large under-explored sectors located along knownmineral trends deemed highly prospective for new gold discoveries.

The Company plans an aggressive 100,000 m (300,000 ft) of drillingover the next two years in order to expand the current resources and totest priority exploration targets over the land holdings."



About $150 per meter--100k of drilling would cost about $15m.
Bullboard Posts